corporate_fare

Pharma Stulln GmbH

Address
Werksstrasse 3

Sponsor Overview

assignment
1
sponsored trial
science
2
molecules
location_city
4
research centres
public
1
country
person_search
4
investigators

Specializations

Ophthalmology

Research activity is centered on eye health, with a clear focus on myopia in children and the clinical need to slow the worsening of nearsightedness during development.

  • Myopia progression
  • Pediatric vision care
  • Refractive error

The sponsor’s clinical interest lies in ophthalmic management strategies aimed at preserving visual function in a pediatric population.

Pediatric Medicine

The funded research addresses children’s health, specifically conditions affecting visual development and the burden of early-onset vision impairment.

  • Childhood eye disorders
  • Visual development
  • Pediatric therapeutic care

This area reflects an interest in therapies relevant to younger patients, where maintaining stable eyesight is a key clinical concern.

Atropine-based ocular therapy

Clinical investigation is directed toward low-dose atropine as an eye drop treatment for controlling myopia progression.

  • Topical ophthalmic treatment
  • Atropine eye drops
  • Dose optimization

The therapeutic scope is concentrated on pharmacologic approaches within ophthalmology, with attention to treatment options suitable for routine pediatric use.

Vision preservation

The sponsor’s research interest includes interventions intended to support long-term visual outcomes by limiting the advancement of myopic refractive change.

  • Myopia control
  • Visual acuity preservation
  • Progression inhibition

These studies are situated within preventive eye care, where the aim is to reduce the clinical impact of progressive childhood myopia.

Sponsored Trials

Trial Name Country Status
Dose-Finding Study of Atropine Sulfate Eye Drops for Inhibition of Myopia Progression in European Pediatric PopulationGermany GermanyNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 2 total (0% not shared with other sponsors)

This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 4 sites collaborated multiple times

This sponsor has worked with 4 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Eye Diseases1 trial
    138 other sponsors

Partnered Research Centres

4 centres
location_city
assignment5
Internationale Innovative Ophthalmochirurgie GbR (I.I.O.)
Address
Martin-Luther-Platz 22/26, Stadtmitte, 40212 Düsseldorf
Learn morearrow_forward
location_city
assignment6
Kardiologie im Spreebogen
Address
Alt Moabit 101b, 10559 Berlin
Learn morearrow_forward
location_city
assignment1
MVZ Augen- und Laserzentren Mitteldeutschland GmbH
Address
Oststraße 2, 04317 Leipzig
Learn morearrow_forward
location_city
assignment120
Saarland University Hospital
Address
Kirrberger Strasse 100, 66421 Homburg
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Pharma Stulln GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.